R. Finch

4.4k total citations · 2 hit papers
83 papers, 3.0k citations indexed

About

R. Finch is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, R. Finch has authored 83 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 20 papers in Pharmacology and 18 papers in Infectious Diseases. Recurrent topics in R. Finch's work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Pneumonia and Respiratory Infections (15 papers) and Antibiotic Use and Resistance (12 papers). R. Finch is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (19 papers), Pneumonia and Respiratory Infections (15 papers) and Antibiotic Use and Resistance (12 papers). R. Finch collaborates with scholars based in United Kingdom, Belgium and Switzerland. R. Finch's co-authors include J T Macfarlane, J T Macfarlane, M.J. Ward, D H Rose, A.D. Macrae, Mark Woodhead, John McCracken, J. Cheesbrough, R. P. Burden and Pradhib Venkatesan and has published in prestigious journals such as The Lancet, Circulation and Spine.

In The Last Decade

R. Finch

81 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PROSPECTIVE STUDY OF THE AETIOLOGY AND OUTCOME OF PNEUMONIA IN THE COMMUNITY

1987 460 citations R. Finch et al. profile →
HOSPITAL STUDY OF ADULT COMMUNITY-ACQUIRED PNEUMONIA

1982 369 citations J T Macfarlane, R. Finch et al. profile →

Peers

Countries citing papers authored by R. Finch

Since Specialization

Citations

This map shows the geographic impact of R. Finch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Finch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Finch more than expected).

Fields of papers citing papers by R. Finch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Finch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Finch. The network helps show where R. Finch may publish in the future.

Co-authorship network of co-authors of R. Finch

This figure shows the co-authorship network connecting the top 25 collaborators of R. Finch. A scholar is included among the top collaborators of R. Finch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Finch. R. Finch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	European quality clearance of new microbiological diagnostics 2012 ·Clinical Microbiology and Infection ·Margareta Ieven, R. Finch, Alex van Belkum	2
2	Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005 2006 ·Journal of Antimicrobial Chemotherapy ·R. Finch, Philip Hunter	77
3	Gram-positive infections: lessons learnt and novel solutions 2006 ·Clinical Microbiology and Infection ·R. Finch	17
4	Tigecycline: in-vitro performance as a predictor of clinical efficacy 2006 ·Clinical Microbiology and Infection ·Peter M. Hawkey, R. Finch	50
5	Lack of development of new antimicrobial drugs: a potential serious threat to public health 2005 ·The Lancet Infectious Diseases ·(unknown), (unknown), R. Finch	238
6	Report of working group 2: Healthcare needs in the organisation and management of infection 2005 ·Clinical Microbiology and Infection ·R. Finch, Waleria Hryniewicz, Johan Van Eldere	3
7	Community-acquired pneumonia: the evolving challenge 2001 ·Clinical Microbiology and Infection ·R. Finch	23
8	Empirical Choice of Antibiotic Therapy in Sepsis 2000 ·Journal of the Royal College of Physicians of London ·R. Finch	1
9	Ciprofloxacin: Efficacy and Indications 2000 ·Journal of Chemotherapy ·R. Finch	11
10	Design of clinical trials in sepsis: problems and pitfalls 1998 ·Journal of Antimicrobial Chemotherapy ·R. Finch	20
11	Conservative management of osteomyelitis in the feet of diabetic patients 1997 ·Diabetic Medicine ·Pradhib Venkatesan, Stephen D Lawn, R.M. Macfarlane, (unknown), R. Finch, William Jeffcoate	85
12	A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens 1996 ·Journal of Antimicrobial Chemotherapy ·Gian Carlo Schito, J. F. Acar, A. Bauernfeind, J Duval, R. Finch, (unknown), Giovanni Federico Nicoletti, Ian Phillips, (unknown), Francisco García Soriano, (unknown), Robert A. Wise	7
13	The management of infective gastroenteritis in adults a consensus statement by an expert panel convened by the British Society for the study of infection 1996 ·Journal of Infection ·M.J.G. Farthing, Ronald B. Feldman, R. Finch, Ray Fox, Clifford Leen, B K Mandal, Peter Moss, Dilip Nathwani, F.J. Nye, A. Percival, Robert C. Read, Lewis Ritchie, W.T.A. Todd, Marsha Wood	22
14	Dirithromycin : a new once-daily macrolide : based on presentations at a symposium held in Rome, 20-21 March 1992 1993 ·Academic Press eBooks ·R. Finch, J. M. T. Hamilton‐Miller, (unknown)	1
15	Hospital Infection Control. Setting up a Cost-effective Programme. 1993 ·Epidemiology and Infection ·R. Finch	1
16	Community-acquired pneumonia 1992 ·Journal of Hospital Infection ·Richard D. Meyer, R. Finch	18
17	Peritonitis complicating continuous ambulatory peritoneal dialysis in Nottingham 1983-1988 1991 ·Journal of Medical Microbiology ·Mark H. Wilcox, R. Finch, R. P. Burden, A G Morgan	3
18	Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negativestaphylococci to polystyrene and silicone rubber 1991 ·Journal of Antimicrobial Chemotherapy ·Mark H. Wilcox, R. Finch, David G. Smith, Paul Williams, S.P. Denyer	33
19	The clinical evaluation of antibacterial drugs: Guidelines of the british society for antimicrobial chemotherapy 1990 ·European Journal of Clinical Microbiology & Infectious Diseases ·R. Finch	4
20	Risks from cannulae used to maintain intravenous access. 1980 ·BMJ ·J T Macfarlane, (unknown), (unknown), (unknown), R. Finch	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact